Arcutis Biotherapeutics, Inc. (ARQT) NASDAQ

25.86

-0.85(-3.18%)

Updated at February 13 04:00PM

Currency In USD

Valuation

Market Cap1.68B
Enterprise Value1.72B
P/E Ratio-74.46
PEG Ratio-1.43
Price/Sales Ratio9.96
Price/Book Ratio20.88
Enterprise/Revenue10.17
Enterprise/EBITDA-135.03

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.14
Operating Margin-0.12

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.3

Income Statement

Revenue196.54M
Revenue/Share2.49
Gross Profit177.41M
EBITDA-109.63M
Net Income-140.04M
Diluted EPS-1.16

Balance Sheet

Total Cash191.07M
Total Cash/Share1.5
Total Debt113.77M
Total Debt/Equity0.72
Current Ratio3.5
Book Value Per Share1.24

Price History

52-Week Change106.71
52-Week High31.77
52-Week Low11.75
Moving Average 50 Days27.86
Moving Average 200 Days20.2

Statistics

Average Volume1.8M
Shares Outstanding122.49M
% Held by Institutions26.93

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A